Skip to main content

Table 1 The baseline characteristics of HCC patients

From: How the National Health Insurance Coverage policy changed the use of lenvatinib for adult patients with advanced hepatocellular carcinoma: a retrospective cohort analysis with real world big data

Variable

Number

%

Gender

Male

9803

77.44

Female

2856

22.56

Age

≥ 18, < 35

210

1.66

≥ 35, < 50

1735

13.71

≥ 50, < 65

6047

47.77

≥ 65, < 80

4201

33.19

≥ 80

466

3.68

Implementation of the NHIC policy

Before

5884

46.48

After

6775

53.52

Medication status

Used

1399

11.05

Unused

11,260

88.95